Valuation: GI Dynamics, Inc.

Market Cap 440K 387K 365K 333K 623K 42.28M 628K 4.38M 1.7M 21.52M 1.65M 1.62M 70.03M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.88M 2.72M 2.48M 4.64M 315M 4.68M 32.63M 12.65M 160M 12.31M 12.05M 521M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 2025-08-04
Director of Finance/CFO 57 2025-07-31
Chief Tech/Sci/R&D Officer - 2023-03-31
Director TitleAgeSince
Director/Board Member - 2020-10-19
Director/Board Member - -
Director/Board Member 69 2023-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
1/28/21 Free

Chairman

1,384,483 0.4875%
1/28/21 Free

Chief Executive Officer

11,075,869 3.8998%

Financials

2019 2020
Net sales - -
Net income -17.33M -15.25M -14.37M -13.11M -24.52M -1.66B -24.71M -172M -66.83M -847M -65.08M -63.67M -2.76B -11.14M -9.8M -9.23M -8.42M -15.75M -1.07B -15.88M -111M -42.94M -544M -41.81M -40.9M -1.77B
Net Debt 2.89M 2.54M 2.39M 2.18M 4.08M 277M 4.12M 28.73M 11.13M 141M 10.84M 10.6M 459M 2.84M 2.5M 2.35M 2.15M 4.02M 273M 4.05M 28.25M 10.95M 139M 10.66M 10.43M 451M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock